NH Investment & Securities Co Ltd (005940)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 24,650.00 |
|---|---|
| 52-week range | 18,173.01 – 40,983.07 |
| Return, 1 month / 3 months | −6.6% / −17.3% |
| Return, 1 year / 3 years | +31.9% / +183.4% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 56.4% |
| Worst drawdown (1 year) | -38.9% |
| Average daily value traded | 13,381.50M KRW |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NH Investment & Securities is a securities firm based in Seoul, Korea, and part of the NongHyup financial group. It offers brokerage services for individual investors, wealth management and advisory services, and investment banking work such as arranging financing and advising on corporate transactions. Its customers include retail investors, institutional clients and companies seeking capital markets services, and it also carries out proprietary trading and research on Korean and overseas markets.
NH Investment & Securities Co Ltd trades under the code 005940 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NH Investment & Securities Co Ltd (005940) trades on the Korea Stock Exchange in Korea. It last closed at KRW 24,650.00 on 19 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 422 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.9% and over the last three months it fell 17.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.5% | ||
| From 52-week high | -35.9% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.3% | ||
| 6-month return | -27.6% | ||
| 12-month return, skipping the last month | 41.3% | ||
| Risk (lower is better) | 51 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 56.4% | ||
| Worst drawdown (1 year) | -38.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 13,381.50M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −6.6% |
| 3 months | −17.3% |
| 6 months | −27.6% |
| 1 year | +31.9% |
| 3 years | +183.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 26,402.00 / 28,836.45 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 914.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 1,300.0000 |
| 28 Mar 2025 | KRW 950.0000 |
| 28 Mar 2024 | KRW 800.0000 |
| 28 Dec 2022 | KRW 700.0000 |
| 29 Dec 2021 | KRW 1,050.0000 |
| 29 Dec 2020 | KRW 700.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.